Earlier this week, the UK’s science minister announced an ambitious plan: to phase out animal testing.
Testing potential skin irritants on animals will be stopped by the end of next year, according to a strategy released on Tuesday. By 2027, researchers are “expected to end” tests of the strength of Botox on mice. And drug tests in dogs and nonhuman primates will be reduced by 2030.
The news follows similar moves by other countries. In April, the US Food and Drug Administration announced a plan to replace animal testing for monoclonal antibody therapies with “more effective, human-relevant models.” And, following a workshop in June 2024, the European Commission also began working on a “road map” to phase out animal testing for chemical safety assessments.
Animal welfare groups have been campaigning for commitments like these for decades. But a lack of alternatives has made it difficult to put a stop to animal testing. Advances in medical science and biotechnology are changing that.
Animals have been used in scientific research for thousands of years. Animal experimentation has led to many important discoveries about how the brains and bodies of animals work. And because regulators require drugs to be first tested in research animals, it has played an important role in the creation of medicines and devices for both humans and other animal

